{"id":"umbilical-cord-mesenchymal-stem-cells","safety":{"commonSideEffects":[{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Infection risk"},{"rate":null,"effect":"Immune rejection"}]},"_chembl":{"chemblId":"CHEMBL5315110","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These allogeneic stem cells derived from umbilical cord tissue exert therapeutic effects by secreting immunomodulatory cytokines, reducing inflammatory responses, and differentiating into various cell lineages to replace damaged tissue. They can engraft into injured areas and promote angiogenesis and tissue remodeling through paracrine mechanisms.","oneSentence":"Umbilical cord-mesenchymal stem cells promote tissue repair and regeneration through immunomodulation, anti-inflammatory effects, and differentiation into specialized cell types.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:37:14.855Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tissue repair and regeneration (specific indications not clearly defined in public literature)"}]},"trialDetails":[{"nctId":"NCT07487766","phase":"PHASE1, PHASE2","title":"The Safety and Efficacy of XytriX in the Treatment of Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"TricelX Inc.","startDate":"2026-05","conditions":"Osteoarthritis","enrollment":50},{"nctId":"NCT07339111","phase":"PHASE3","title":"Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis","status":"RECRUITING","sponsor":"Medipost, Inc.","startDate":"2026-03-11","conditions":"Knee Cartilage Defects","enrollment":300},{"nctId":"NCT07479043","phase":"PHASE3","title":"To Evaluate the Safety and Potential Therapeutic Activity of JadiCell™, an Investigational Umbilical Cord-Derived Mesenchymal Stem Cell Therapy, in Patients Diagnosed With Acute Respiratory Distress Syndrome (ARDS).","status":"NOT_YET_RECRUITING","sponsor":"Breathe Biologics, Inc.","startDate":"2026-07","conditions":"Acute Respiratory Distress Syndrome","enrollment":128},{"nctId":"NCT07480161","phase":"PHASE2, PHASE3","title":"Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-12-29","conditions":"Erectile Dysfunction With Diabetes Mellitus","enrollment":90},{"nctId":"NCT07472270","phase":"PHASE1","title":"Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment","status":"NOT_YET_RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2026-03-15","conditions":"Liver Cirrhosis","enrollment":12},{"nctId":"NCT07457125","phase":"PHASE1, PHASE2","title":"The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-03-10","conditions":"Mild to Moderate Alzheimer's Disease","enrollment":33},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT07431645","phase":"PHASE1","title":"Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-04-01","conditions":"Radiation-Induced Xerostomia, Head and Neck Cancer","enrollment":10},{"nctId":"NCT07441720","phase":"PHASE2","title":"Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2026-02-28","conditions":"Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia","enrollment":25},{"nctId":"NCT07439848","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2023-12-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":15},{"nctId":"NCT07441226","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients","status":"RECRUITING","sponsor":"RSUP Persahabatan","startDate":"2025-08-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":20},{"nctId":"NCT04314687","phase":"PHASE1, PHASE2","title":"Stem Cell and Conditioned Medium for Cerebral Palsy","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2021-10-13","conditions":"Cerebral Palsy","enrollment":78},{"nctId":"NCT05008588","phase":"PHASE1, PHASE2","title":"Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-05-30","conditions":"Ischemic Stroke","enrollment":15},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT04314661","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2020-08-03","conditions":"Osteoarthritis, Knee","enrollment":31},{"nctId":"NCT04357600","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B","status":"ENROLLING_BY_INVITATION","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2018-05-17","conditions":"Liver Cirrhoses","enrollment":12},{"nctId":"NCT05786287","phase":"","title":"Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa","status":"NOT_YET_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-05","conditions":"Retinitis Pigmentosa","enrollment":18},{"nctId":"NCT05909488","phase":"PHASE2, PHASE3","title":"Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II","status":"NOT_YET_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-05","conditions":"Retinitis Pigmentosa","enrollment":30},{"nctId":"NCT03158896","phase":"PHASE1","title":"Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-07-09","conditions":"Acute Graft Versus Host Disease","enrollment":24},{"nctId":"NCT07429253","phase":"PHASE1, PHASE2","title":"Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-01-09","conditions":"Androgenetic Alopecia","enrollment":40},{"nctId":"NCT07416578","phase":"NA","title":"Clinical Study on the Effect of Umbilical Cord Mesenchymal Stem Cell Exosomes on Endometrial Repair of Intrauterine Adhesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2026-01-01","conditions":"Intrauterine Adhesions, Exosomes","enrollment":60},{"nctId":"NCT07413549","phase":"PHASE1, PHASE2","title":"Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis","status":"RECRUITING","sponsor":"Beijing Tuohua Weiye Biotechnology Co., Ltd.","startDate":"2025-02-25","conditions":"Decompensated Hepatitis B Cirrhosis","enrollment":76},{"nctId":"NCT07413978","phase":"PHASE1, PHASE2","title":"A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome","status":"RECRUITING","sponsor":"Changchun Tuohua Pharmaceutical Co., Ltd.","startDate":"2025-04-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":36},{"nctId":"NCT05697718","phase":"PHASE1","title":"Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke","status":"COMPLETED","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2023-04-10","conditions":"Ischemic Stroke","enrollment":18},{"nctId":"NCT07299123","phase":"PHASE1, PHASE2","title":"Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese PLA General Hospital","startDate":"2023-08-01","conditions":"Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia","enrollment":40},{"nctId":"NCT07212335","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-10-01","conditions":"Immune Effector Cell Associated Hematotoxicity","enrollment":15},{"nctId":"NCT07400328","phase":"PHASE2","title":"Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-01-15","conditions":"Oral Mucositis, Stomatitis, Gastrointestinal Mucositis","enrollment":22},{"nctId":"NCT06949137","phase":"PHASE1","title":"Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture","status":"ACTIVE_NOT_RECRUITING","sponsor":"Help Therapeutics","startDate":"2025-06-20","conditions":"Osteoporosis in Post-menopausal Women, Osteoporosis","enrollment":9},{"nctId":"NCT07396155","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-07-01","conditions":"Diabetic Nephropathy Type 2","enrollment":10},{"nctId":"NCT07295067","phase":"PHASE1","title":"Extracellular Vesicles for the Treatment of Syringomyelia","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-23","conditions":"Syringomyelia","enrollment":18},{"nctId":"NCT07304440","phase":"PHASE1, PHASE2","title":"Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study","status":"RECRUITING","sponsor":"Adia Med of Winter Park LLC","startDate":"2026-01-12","conditions":"Autism Spectrum Disorder, Autism, ASD","enrollment":100},{"nctId":"NCT07373054","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia","status":"RECRUITING","sponsor":"Fujian Medical University Union Hospital","startDate":"2025-11-06","conditions":"Androgenic Alopecia","enrollment":18},{"nctId":"NCT01733186","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects","status":"COMPLETED","sponsor":"Medipost, Inc.","startDate":"2013-01-07","conditions":"Degeneration Articular Cartilage Knee","enrollment":12},{"nctId":"NCT07374679","phase":"","title":"Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2026-01-26","conditions":"Rotator Cuff Disease","enrollment":21},{"nctId":"NCT06677931","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma","status":"COMPLETED","sponsor":"Fujian Medical University Union Hospital","startDate":"2024-08-28","conditions":"Melasma","enrollment":30},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT07337863","phase":"PHASE2, PHASE3","title":"A Phase II/III Randomized Double-Blind Multicenter Study Comparing UC-MSC-Derived Secretome and Sodium Hyaluronate in Patients With Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sriwijaya","startDate":"2026-01-01","conditions":"Knee Osteoarthritis (Knee OA)","enrollment":50},{"nctId":"NCT06981741","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint","status":"RECRUITING","sponsor":"BIONCaRT GmbH","startDate":"2025-11-10","conditions":"Cartilage Damage","enrollment":55},{"nctId":"NCT07265349","phase":"PHASE1, PHASE2","title":"A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2025-12-26","conditions":"Coronary Artery Bypass Grafting (CABG), Chronic Heart Failure, Chronic Ischemic Cardiomyopathy","enrollment":51},{"nctId":"NCT07319533","phase":"PHASE2","title":"Clinical Trial Investigating the Effect of Exosomes as a Complementary Treatment in Severe to Moderate Erectile Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Labbafinejad Medical Center","startDate":"2026-01","conditions":"Erectile Dysfunction, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, Erectile Dysfunction Due to Arterial Disease","enrollment":70},{"nctId":"NCT06129175","phase":"PHASE2, PHASE3","title":"UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX)","status":"RECRUITING","sponsor":"Cytopeutics Sdn. Bhd.","startDate":"2023-12-19","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT03847844","phase":"PHASE1, PHASE2","title":"UCMSCs as Front-line Approach of Treatment for Patients With aGVHD","status":"COMPLETED","sponsor":"Cytopeutics Sdn. Bhd.","startDate":"2019-02-01","conditions":"Acute-graft-versus-host Disease","enrollment":26},{"nctId":"NCT07313020","phase":"EARLY_PHASE1","title":"Handheld MPI Imaging to Track Stem Cells in Osteoarthritis","status":"ENROLLING_BY_INVITATION","sponsor":"Soochow University","startDate":"2025-12-16","conditions":"Knee Arthritis Osteoarthritis","enrollment":10},{"nctId":"NCT04434768","phase":"PHASE1","title":"Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ever Supreme Bio Technology Co., Ltd.","startDate":"2020-12-02","conditions":"Acute Stroke","enrollment":10},{"nctId":"NCT05162326","phase":"PHASE1","title":"BC-101 in Treatment of Nasolabial Fold Wrinkles","status":"NOT_YET_RECRUITING","sponsor":"Bright Cell, Inc.","startDate":"2026-12-01","conditions":"Nasolabial Fold Wrinkles","enrollment":9},{"nctId":"NCT04452097","phase":"PHASE1, PHASE2","title":"Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS","status":"WITHDRAWN","sponsor":"Baylx Inc.","startDate":"2026-06-01","conditions":"COVID-19, ARDS, Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT05468502","phase":"PHASE1","title":"Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)","status":"COMPLETED","sponsor":"Shanghai Life Science & Technology","startDate":"2022-10-10","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":17},{"nctId":"NCT03828344","phase":"PHASE1","title":"Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Baylx Inc.","startDate":"2026-12-01","conditions":"Rheumatoid Arthritis","enrollment":16},{"nctId":"NCT05494723","phase":"PHASE1","title":"Safety and Efficacy of YB-1113 in Treatment of POI","status":"NOT_YET_RECRUITING","sponsor":"Bright Cell, Inc.","startDate":"2026-12-09","conditions":"POI","enrollment":6},{"nctId":"NCT07281690","phase":"PHASE3","title":"Enhancing Skin Rejuvenation Using Laser and Exosomes","status":"COMPLETED","sponsor":"Laser Beamer Skincare","startDate":"2025-03-01","conditions":"Laser Therapy, Exosomes","enrollment":20},{"nctId":"NCT06589271","phase":"PHASE1","title":"SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Lumbar Disc Degeneration","enrollment":20},{"nctId":"NCT06503471","phase":"PHASE1","title":"SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Infertility, Female","enrollment":24},{"nctId":"NCT03816852","phase":"PHASE2","title":"The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Premature Ovarian Failure","enrollment":12},{"nctId":"NCT03378414","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia","status":"NOT_YET_RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3","enrollment":45},{"nctId":"NCT03383081","phase":"PHASE2","title":"The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Osteoarthritis, Knee","enrollment":60},{"nctId":"NCT04104412","phase":"PHASE1","title":"The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2019-08-15","conditions":"Lumbar Discogenic Pain","enrollment":242},{"nctId":"NCT07203599","phase":"PHASE1, PHASE2","title":"A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes","status":"RECRUITING","sponsor":"Shenzhen People's Hospital","startDate":"2025-09-20","conditions":"Androgenic Alopecia","enrollment":59},{"nctId":"NCT03826433","phase":"PHASE1","title":"hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Hepatitis B","enrollment":20},{"nctId":"NCT07245875","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell Secretome Administration in Severe Erectile Dysfunction Non-responsive to Sildenafil","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2024-04-12","conditions":"Erectile Dysfunction, Diabetes Mellitus Type 2","enrollment":12},{"nctId":"NCT07243561","phase":"PHASE1, PHASE2","title":"Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism","status":"RECRUITING","sponsor":"Dongfang People's Hospital","startDate":"2025-11-30","conditions":"Autism Spectrum Disorder (ASD, Prospective Study","enrollment":40},{"nctId":"NCT06578039","phase":"PHASE1","title":"Phase 1 Clinical Trial of CordSTEM-ST","status":"COMPLETED","sponsor":"CHABiotech CO., Ltd","startDate":"2024-08-30","conditions":"Premature Ovarian Insufficiency","enrollment":6},{"nctId":"NCT07232563","phase":"PHASE1","title":"Exploratory Study of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2025-12-01","conditions":"Ischemic Stroke","enrollment":9},{"nctId":"NCT07232147","phase":"PHASE1","title":"Clinical Research on Stem Cell Therapy for Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.","startDate":"2025-12-01","conditions":"Parkinson Disease (PD), Neurodegenerative Diseases, Movement Disorders","enrollment":20},{"nctId":"NCT07084012","phase":"PHASE2","title":"A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS","status":"RECRUITING","sponsor":"Shenzhen Wingor Biotechnology Co., Ltd.","startDate":"2025-08-27","conditions":"Acute Ischemic Stroke AIS","enrollment":60},{"nctId":"NCT07197606","phase":"PHASE2","title":"Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2025-10-01","conditions":"Ischemic Stroke","enrollment":86},{"nctId":"NCT07183761","phase":"PHASE2","title":"A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects With Moderate to Severe Diabetic Peripheral Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Min Long","startDate":"2025-10-01","conditions":"Diabetic Peripheral Neuropathy (DPN)","enrollment":140},{"nctId":"NCT04971980","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Baylx Biotech Co., Ltd.","startDate":"2021-04-12","conditions":"Rheumatoid Arthritis","enrollment":9},{"nctId":"NCT07169838","phase":"","title":"Comparative Study of Perinatal Tissues for Clinical-Grade Mesenchymal Stem Cell Production and Cost-Effectiveness","status":"COMPLETED","sponsor":"Kayseri City Hospital","startDate":"2023-01-01","conditions":"Regenerative Medicine, Stem Cell Banking, Perinatal Medical Waste","enrollment":160},{"nctId":"NCT03042143","phase":"PHASE1, PHASE2","title":"Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Belfast Health and Social Care Trust","startDate":"2019-01-07","conditions":"Acute Respiratory Distress Syndrome","enrollment":129},{"nctId":"NCT06167473","phase":"NA","title":"Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD","status":"ACTIVE_NOT_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2023-11-28","conditions":"End-stage Liver Diseases","enrollment":22},{"nctId":"NCT07131540","phase":"PHASE1","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":10},{"nctId":"NCT06984497","phase":"NA","title":"Human Umbilical Cord-mesenchymal Stem Cells Via Different Transplantation Routes in ESLD","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-09","conditions":"End-Stage Liver Diseases","enrollment":32},{"nctId":"NCT07137559","phase":"","title":"CELZ-201-DDT for the Treatment of Chronic Lower Back Pain","status":"AVAILABLE","sponsor":"Creative Medical Technology Holdings Inc","startDate":"","conditions":"Chronic Back Pain, Degenerative Disc Disease Lumbar","enrollment":""},{"nctId":"NCT07131306","phase":"PHASE2","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem Cell Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patient- Phase-II Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2027-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":100},{"nctId":"NCT07131683","phase":"PHASE1, PHASE2","title":"hUC-MSC-Exo Therapy for Autoimmune Encephalitis","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-11-01","conditions":"Autoimmune Encephalitis","enrollment":38},{"nctId":"NCT07131150","phase":"PHASE2","title":"Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis","status":"NOT_YET_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-08-31","conditions":"Idiopathic Pulmonary Fibrosis (IPF)","enrollment":66},{"nctId":"NCT04919135","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-10-19","conditions":"Frailty","enrollment":158},{"nctId":"NCT07075315","phase":"PHASE3","title":"National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2028-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":100},{"nctId":"NCT07122648","phase":"PHASE2","title":"Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis","status":"NOT_YET_RECRUITING","sponsor":"Paean Biotechnology Inc.","startDate":"2025-12","conditions":"Polymyositis, Dermatomyositis","enrollment":36},{"nctId":"NCT05939167","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage","status":"RECRUITING","sponsor":"Cell Energy Life Sciences Group Co. LTD","startDate":"2023-12-10","conditions":"AIDS","enrollment":150},{"nctId":"NCT05532943","phase":"PHASE1, PHASE2","title":"Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis","status":"RECRUITING","sponsor":"Ever Supreme Bio Technology Co., Ltd.","startDate":"2023-09-08","conditions":"Multiple Sclerosis","enrollment":41},{"nctId":"NCT04255147","phase":"PHASE1","title":"Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-10-17","conditions":"Bronchopulmonary Dysplasia","enrollment":9},{"nctId":"NCT06607900","phase":"PHASE1","title":"hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-07-01","conditions":"Alzheimer Disease, Parkinson Disease, Lewy Body Dementia","enrollment":120},{"nctId":"NCT05984628","phase":"NA","title":"Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds","status":"RECRUITING","sponsor":"Fujian Medical University Union Hospital","startDate":"2021-10-20","conditions":"Skin Wound, Scar, Hypertrophic","enrollment":88},{"nctId":"NCT07041801","phase":"PHASE1, PHASE2","title":"Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"Shenzhen Beike Bio-Technology Co., Ltd.","startDate":"2025-06-28","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":58},{"nctId":"NCT05971342","phase":"NA","title":"The Safety and Efficacy of Alveolar Bone Defect Repair Induced by Gelatin Sponge-loaded Apoptotic Vesicle Complex","status":"COMPLETED","sponsor":"Fifth Affiliated Hospital of Guangzhou Medical University","startDate":"2023-08-20","conditions":"Third Molar Extraction","enrollment":43},{"nctId":"NCT05147675","phase":"PHASE1","title":"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2022-12-01","conditions":"Osteoarthritis, Spinal Arthritis","enrollment":92},{"nctId":"NCT07011199","phase":"PHASE1","title":"Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia","status":"NOT_YET_RECRUITING","sponsor":"Universitas Diponegoro","startDate":"2025-06-17","conditions":"Biliary Atresia, Kasai Portoenterostomy, Mesenchymal Stem Cell Transplantation","enrollment":14},{"nctId":"NCT06534528","phase":"PHASE1","title":"Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Life Science & Technology","startDate":"2025-10-01","conditions":"Interstitial Lung Disease","enrollment":24},{"nctId":"NCT06882811","phase":"EARLY_PHASE1","title":"Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis","status":"RECRUITING","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2025-05-22","conditions":"Sepsis","enrollment":180},{"nctId":"NCT06981338","phase":"PHASE1, PHASE2","title":"Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation","status":"NOT_YET_RECRUITING","sponsor":"Institut Guttmann","startDate":"2025-09-01","conditions":"Spinal Cord Injuries (SCI), Spinal Cord Injury, Traumatic Spinal Cord Injuries","enrollment":10},{"nctId":"NCT05495711","phase":"PHASE1","title":"hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility","status":"COMPLETED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2022-08-01","conditions":"Infertility, Female","enrollment":25},{"nctId":"NCT03184935","phase":"PHASE1, PHASE2","title":"Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Myelodysplastic Syndromes","enrollment":40},{"nctId":"NCT03186456","phase":"PHASE1","title":"The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Cerebral Infarction","enrollment":40},{"nctId":"NCT03180450","phase":"PHASE1, PHASE2","title":"The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT03180463","phase":"PHASE1, PHASE2","title":"The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Osteonecrosis of Femoral Head","enrollment":30},{"nctId":"NCT05039411","phase":"PHASE1","title":"Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease","status":"RECRUITING","sponsor":"CryoCord Sdn Bhd","startDate":"2022-03-01","conditions":"Perianal Fistula Due to Crohn's Disease, Fistula in Ano","enrollment":5},{"nctId":"NCT06853522","phase":"EARLY_PHASE1","title":"hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-05-30","conditions":"Ulcerative Colitis (UC)","enrollment":40},{"nctId":"NCT04040348","phase":"PHASE1","title":"Alzheimer's Disease Stem Cells Multiple Infusions","status":"COMPLETED","sponsor":"Bernard (Barry) Baumel","startDate":"2019-10-08","conditions":"Alzheimer Disease","enrollment":6}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BRONCHITIS"},{"count":1,"reaction":"GAIT DISTURBANCE"},{"count":1,"reaction":"ILLNESS"},{"count":1,"reaction":"JOINT SWELLING"},{"count":1,"reaction":"PAIN IN EXTREMITY"},{"count":1,"reaction":"PERIPHERAL SWELLING"},{"count":1,"reaction":"SQUAMOUS CELL CARCINOMA"}],"_approvalHistory":[],"publicationCount":2168,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["UC-MSCs"],"phase":"marketed","status":"active","brandName":"umbilical cord-mesenchymal stem cells","genericName":"umbilical cord-mesenchymal stem cells","companyName":"General Hospital of Shenyang Military Region","companyId":"general-hospital-of-shenyang-military-region","modality":"Biologic","firstApprovalDate":"","aiSummary":"Umbilical cord-mesenchymal stem cells promote tissue repair and regeneration through immunomodulation, anti-inflammatory effects, and differentiation into specialized cell types. Used for Tissue repair and regeneration (specific indications not clearly defined in public literature).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}